Professional Documents
Culture Documents
NAME
ROLL NO.
THEORY :
Ethidium bromide [3,8-diamino-5-ethyl-6-phenylphenanthiridinium
bromide]is commonly used to probe DNA structure in drug-DNA and
protein-DNA interactions. It binds nucleic acids via intercalative mode
and cause major changes to DNA and RNA structures. As a drug, it has
binds to DNA duplexes with moderate affinity (Kd ranges from 0.2
200M) and variable stoichiometry (3 6 equivalents of Ethidium per
helical repeat) depending on the sequence of the duplex. Ethidium binds
to different duplex nucleic acids with a free energy range of 5.38.8
kcal/mole, depending on the structure and sequence of the nucleic acid.
The unwinding of DNA from the binding of intercalating drugs relaxes
negative supercoils. The unwinding angles of EtBr are about 26 per
intercalated molecule respectively, it takes ~13 intercalated molecules to
unwind the helix by 360 or remove one turn of the DNA double helix
(with an unwinding angle of 26). Unwinding from intercalation lowers
the value of LO. Therefore, as an increasing number of molecules
intercalates into DNA, the value of LO decreases. In case of circular DNA,
which has got no free ends, after enough EtBr has bound to DNA it
causes circular DNA to become twisted to form a 8 shaped figure. As
more Ethidium binds to DNA, the figure gets more twisted, until a time
comes when it is unable to twist any further.
A time comes when the DNA gets saturated with EtBr, till there is no
further increase in kinking of DNA.
Non intercalative binding, relatively weak form of binding, that only
occurs when the space between the base pairs of DNA have become
saturated with EtBr. The former (intercalative) mode of binding is stronger
one, while the latter is weak. In
spectrophotometric titration of EtBr binding to DNA, an Isosbestic point is
observed at 518nm. Free Ethidium Bromide has a maximum absorbance
at 485.9761nm. As more and more EtBr binds to DNA, the free Ethidium
bromide amount decreases. Therefore, the absorption (maximum)
decreases accordingly with subsequent addition of DNA, with a spectral
shift in maximum absorbance.
PROTOCOL:
1mg EtBr was weighed in a digital weighing balance. It was mixed
thoroughly with 1ml distilled water.
700uL distilled water was taken in a quartz cuvette and through the
spectrophotometer, base line correction was meted out to cancel
out the noise of several peaks due to air as well as the solvent itself.
To it, 20uL of EtBr was added, mixed by inversion by using paraffin
paper on top of the cuvette opening.
Since native EtBr peak was small, 20uL was further added to the
cuvette containing 720uL solution to attain standardisation.
10uL EtBr was again added till threshold is reached and peak gets
flattened. The wavelength maxima of the Absorbance spectrum was
noted and the corresponding absorbance value was taken for
further calculation.
3. 10l of stock DNA solution was added to the above solution in a
cuvette and its absorbance was noted.
The above step was repeated several times with subsequent
addition of DNA (15,20,25,35,45,55,75,85,95,105 l) and the
absorbance was noted until a time, when there was no significant
spectral shift was noticed.
OD = cl
C = Concentration of DNA
From this, the concentration of DNA in each addition was found out.
PLOT :
1. A graph depicting the differences in absorbances in various
concentrations of DNA-EtBr was plotted; with Optical
Density(Absorbance) in Y axis and Wavelength in X axis. The
isobestic point was determined from the plot.
2. A graph was plotted with A/A in Y axis, where A = A-Ax and
where, A = maximum absorbance (at the wavelength where the
peak was observed).
From this graph, binding affinity (K) could be found out. K is the
dissociation constant indicating how strongly the ligand is bound to
DNA and K~1/C .
3. A hill plot for DNA-EtBr interaction was plotted. The hill plot depicts
two straight lines indicating two different modes of binding.
Here, ln/1- is plotted in Y axis with ln[DNA] in X axis; where
= fraction of binding sites of DNA filled with Ethidium Bromide.
Mathematically, is obtained by following the formula
= (O.D.EtBr O.D.EtBr-DNA)/(O.D.EtBr O.D.min)
INSTRUMENTATION :
The experiment was carried out in a spectrophotometer. The
instrument consists of a light source, a monochromator (for
wavelength selection), a transparent sample holder called a
cuvette, a light detector and a meter or recorder, for measuring
the output of detector. In our instrument the readings from
detector were displayed in an inbuilt monitor, along with a graph
and the same data and graph were printed on printer paper
associated with the spectrophotometer.
We made a measurement of the light transmitted by solvent
(here water), then the instrument is adjusted to read zero
absorbance when the solvent alone is measured(zeroing the
instrument). Then, the instrument so adjusted the absorbance of
sample is read directly.
In our experiment, as EtBr is red in colour, so we set the
instrument to scan and record absorbance value(optical density)
over arrange of 400-600nm.
We obtained the peak absorbance for Ethidium Bromide at
489.9289 nm.
CALCULATION :
For DNA Concentration :
OD of DNA at 260 nm (OD 260) = 0.2707 = A
A = Cl ; = 6600 L/Mole/cm
0.2707 = Cl
= 41.015moles/L
0.35
0.30
0.20
A/ A K= 1/ [DNA] (M )
-1
0.15 -4
0.12125 = 1/ [12.8355*10 ]
-1
= 779.90 M
0.10
0.05
12.8355
0.00
0 20 40
[DNA] * 10-4
No. of (nm) A AX A=(A- W 1- /1- Ln(/1-) Ln[DNA]
Observations AX) Y-axis X-axis
(DNA0l)
(10L) 3
10. DNA(85l) 0.19474 0.14117 0.0536 0.9069 0.0931 9.7411 2.2764 5.8540
11. DNA(95l) 0.19474 0.1388 0.05591 0.9459 0.0541 17.4843 2.8613 5.9652
)
A= ODEtBr
AX= OD(EtBr-DNA)
W= ODEtBr-ODMIN
= ODEtBr- OD(EtBr-DNA)/W
3 y = 3.278x - 9.355
2
0
ln(/1-)
0 1 2 3 4
-1 ln(/1-)
ln (/1-)
-2
-3
-4
y = 1.9677x - 5.322
-5
-6
ln [DNA]
INTERACTION OF DNA WITH ETHIDIUM BROMIDE
INTERPRETATION :
n1 = 3.278 n2 = 1.9677
SIGNIFICANCE :
Binding affinity of one ligand with DNA shows how tightly the
ligand is bound to DNA; indicating the amount of affinity of ligand
to DNA. This maybe compared with binding affinity of another
ligand and can be put to use in drug designing, as to find which is
more potent.
EtBr can be used for site directed mutagenesis.
The interaction between DNA-intercalating agents provides
information regarding the biological activity of planar
chromophore.